Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients

References

• Penn L, White M, Lindström J, den Boer AT, Blaak E, Eriksson JG, Feskens E, Ilanne-Parikka P, Keinänen-Kiukaanniemi SM, Walker M, Mathers JC, Uusitupa M, Tuomilehto J. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 2013;8:e57143.
   PubMed Web of Science ®Google Scholar
• Vaz JA, Patnaik A. Diabetes mellitus: exploring the challenges in the drug development process. Perspect Clin Res 2012;3:109–12.
   PubMedGoogle Scholar
• World Health Organization (WHO). Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO, 2006.
   Google Scholar
• Yamane T, Yokoyama A, Kitahara Y, Miyamoto S, Haruta Y, Hattori N, Yamane K, Hara H, Kohno N. Cross-sectional and prospective study of the association between lung function and prediabetes. BMJ Open 2013;3: e002179.
   Google Scholar
• Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19: 708–23.
   PubMed Web of Science ®Google Scholar
• Marzouk M, Soliman AM, Omar TY. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats. Eur Rev Med Pharmacol Sci 2013;17:559–65.
   PubMedGoogle Scholar
• Suresha BS, Vasantha KY, Sattur AP, Srinivasan K. Beneficial influence of fungal metabolite nigerloxin on diabetes-induced oxidative stress in experimental rats. Can J Physiol Pharmacol 2013;91:149–56.
   PubMed Web of Science ®Google Scholar
• Korkmaz GG, Uzun H, Cakatay U, Aydin S. Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury. Clin Invest Med 2012;35:E370–7.
   Google Scholar
• Cakatay U, Kayali R. The evaluation of altered redox status in plasma and mitochondria of acute and chronic diabetic rats. Clin Biochem 2006;39:907–12.
   PubMed Web of Science ®Google Scholar
• Serin O, Konukoglu D, Firtina S, Mavis O. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Horm Metab Res 2007;39:207–11.
   PubMed Web of Science ®Google Scholar
• Gradinaru D, Borsa C, Ionescu C, Margina D, Prada GI, Jansen E. Vitamin D status and oxidative stress markers in elderly with impaired fasting glucose and type 2 diabetes mellitus. Aging Clin Exp Res 2012;24:595–602
   PubMed Web of Science ®Google Scholar
• Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5.
   PubMed Web of Science ®Google Scholar
• Zuwała-Jagiełło J, Warwas M, Pazgan-Simon M. Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim Pol 2012; 59:661–7.
   PubMedGoogle Scholar
• Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010;95: 586–91.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus – preliminary report. Dis Markers 2008;24:311–7.
   PubMed Web of Science ®Google Scholar
• Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007;40:248–54.
   PubMed Web of Science ®Google Scholar
• Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvaç S, Akyol M, Kandemir O, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract 2010; 89:231–8.
   PubMed Web of Science ®Google Scholar
• Korkmaz GG, Altınoglu E, Civelek S, Sozer V, Erdenen F, Tabak O, Uzun H. The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism 2013;62:828–35.
   PubMedGoogle Scholar
• Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, Sun X, Liu L. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007;112: 599–606.
   PubMed Web of Science ®Google Scholar
• Baschetti R. Evolutionary legacy: form of ingestion, not quantity, is the key factor in producing the effects of sugar on human health. Med Hypotheses 2004;63:933–8.
   PubMedGoogle Scholar
• Gelisgen R, Genc H, Kayali R, Oncul M, Benian A, Guralp O, Uludag S, Cakatay U, Albayrak M, Uzun H. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 2011;94: 404–9.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 1996;239:70–6.
   PubMed Web of Science ®Google Scholar
• Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, Kazemi-Bajestani SM, Paletas K, Pegiou T, Koliakos G. Prooxidant–antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008;41: 375–80.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia – a preliminary report. J Emerg Med 2000;19: 311–5.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia- modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004;50: 1656–60.
   PubMed Web of Science ®Google Scholar
• Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005;31:551–7.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007;77:188–92.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus – preliminary report. Dis Markers 2008;24:311–7.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin Invest Med 2010;33:E109.
   PubMed Web of Science ®Google Scholar
• Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51: 597–604.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–13.
   PubMed Web of Science ®Google Scholar
• Han K, Jia N, Yang L, Min LQ. Correlation between ischemia-modified albumin and lipid levels in patients with acute cerebrovascular disease. Mol Med Rep 2012; 6:621–4.
   PubMed Web of Science ®Google Scholar
• Singh N, Bhardwaj P, Pandey RM, Saraya A. Oxidative stress and antioxidant capacity in patients with chronic pancreatitis with and without diabetes mellitus. Indian J Gastroenterol 2012;31:226–31.
   PubMedGoogle Scholar
• Thiyagarajan R, Subramanian SK, Sampath N, Madanmohan Trakroo, Pal P, Bobby Z, Paneerselvam S, Das AK. Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study. PLoS One 2012;7: e41889.
   Google Scholar
• Al-Shebly MM, Mansour MA. Evaluation of oxidative stress and antioxidant status in diabetic and hypertensive women during labor. Oxid Med Cell Longev 2012;2012: 329743.
   PubMed Web of Science ®Google Scholar
• Savu O, Ionescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R, Stoian I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res 2012;40:709–16.
   PubMed Web of Science ®Google Scholar
• Savu O, Bradescu OM, Serafinceanu C, Iosif L, Tirgoviste CI, Stoian I. Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset. Redox Rep 2013;18:56–62.
   PubMed Web of Science ®Google Scholar